Cargando…

Antiplatelet and Anticoagulation Therapy

Aspirin has been in clinical use for over 100 years, making it one of the oldest commonly used drugs in medicine, and is now predominantly used as an antiplatelet agent. Major new antiplatelet drug classes have recently become available for the clinician that offer the promise of major improvements...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Ferro, Albert (Editor ), Garcia, David A. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London : Springer London : Imprint: Springer, 2013.
Edición:1st ed. 2013.
Colección:Current Cardiovascular Therapy,
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-1-4471-4297-3
003 DE-He213
005 20220322182828.0
007 cr nn 008mamaa
008 121026s2013 xxk| s |||| 0|eng d
020 |a 9781447142973  |9 978-1-4471-4297-3 
024 7 |a 10.1007/978-1-4471-4297-3  |2 doi 
050 4 |a RC666-701.2 
072 7 |a MJD  |2 bicssc 
072 7 |a MED010000  |2 bisacsh 
072 7 |a MJD  |2 thema 
082 0 4 |a 616.12  |2 23 
245 1 0 |a Antiplatelet and Anticoagulation Therapy  |h [electronic resource] /  |c edited by Albert Ferro, David A. Garcia. 
250 |a 1st ed. 2013. 
264 1 |a London :  |b Springer London :  |b Imprint: Springer,  |c 2013. 
300 |a X, 247 p. 37 illus., 26 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Current Cardiovascular Therapy,  |x 2946-8191 
505 0 |a Antiplatelet agents: current and novel -- Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitoring -- Anticoagulant Drugs: Current and Novel -- Primary prevention of cardiovascular disease -- Approaches to the Prophylaxis and Treatment of Venous and Cardiac Thromboembolic Disease. 
520 |a Aspirin has been in clinical use for over 100 years, making it one of the oldest commonly used drugs in medicine, and is now predominantly used as an antiplatelet agent. Major new antiplatelet drug classes have recently become available for the clinician that offer the promise of major improvements in the treatment and prevention of arterial thrombotic disease. In the field of anticoagulation, the vitamin K antagonists such as warfarin have not been available for as long as aspirin in the antiplatelet field, and have also had very little in the way of competition until recently; although a number of parenteral anticoagulants have been available, the vitamin K antagonists have been the only orally active anticoagulant drugs. The last few years have seen the arrival of new drug classes, the orally active direct thrombin inhibitors and factor Xa antagonists, which offer a number of advantages, but not without important drawbacks. In the face of these important advances in both antiplatelet and anticoagulant therapy, clinicians often feel confused, even overwhelmed, as to what is now available and which drugs are useful (and indicated) in which circumstances. Antiplatelet and Anticoagulant Therapy is designed with such people in mind. It is written in an easy-to-follow format and with many illustrations to aid clarity and the assimilation of information. Each chapter is written by established authorities in their fields who are also experienced in explaining often complex concepts. The result is a unique book which is not only comprehensive but also clear and useful for the busy medical practitioner. 
650 0 |a Cardiology. 
650 0 |a Medical sciences. 
650 1 4 |a Cardiology. 
650 2 4 |a Health Sciences. 
700 1 |a Ferro, Albert.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Garcia, David A.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9781447142980 
776 0 8 |i Printed edition:  |z 9781447142966 
830 0 |a Current Cardiovascular Therapy,  |x 2946-8191 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-1-4471-4297-3  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)